BR9106377A - Composicao e processo para o tratamento topico de tecido lesado ou enfermo - Google Patents

Composicao e processo para o tratamento topico de tecido lesado ou enfermo

Info

Publication number
BR9106377A
BR9106377A BR919106377A BR9106377A BR9106377A BR 9106377 A BR9106377 A BR 9106377A BR 919106377 A BR919106377 A BR 919106377A BR 9106377 A BR9106377 A BR 9106377A BR 9106377 A BR9106377 A BR 9106377A
Authority
BR
Brazil
Prior art keywords
injured
composition
topical treatment
nursing
tissue
Prior art date
Application number
BR919106377A
Other languages
English (en)
Inventor
R Martin Emanuele
Robert L Hunter
Original Assignee
Cytrx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytrx Corp filed Critical Cytrx Corp
Publication of BR9106377A publication Critical patent/BR9106377A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR919106377A 1990-04-26 1991-04-25 Composicao e processo para o tratamento topico de tecido lesado ou enfermo BR9106377A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51350990A 1990-04-26 1990-04-26
US68703491A 1991-04-22 1991-04-22
PCT/US1991/002912 WO1991016058A1 (en) 1990-04-26 1991-04-25 Composition and method for topical treatment of damaged or diseased tissue

Publications (1)

Publication Number Publication Date
BR9106377A true BR9106377A (pt) 1993-04-27

Family

ID=27057898

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919106377A BR9106377A (pt) 1990-04-26 1991-04-25 Composicao e processo para o tratamento topico de tecido lesado ou enfermo

Country Status (10)

Country Link
EP (1) EP0526578A4 (pt)
JP (1) JPH0776175B2 (pt)
CN (1) CN1058341A (pt)
AU (1) AU647484B2 (pt)
BR (1) BR9106377A (pt)
CA (1) CA2081340A1 (pt)
IE (1) IE911403A1 (pt)
IL (1) IL97976A0 (pt)
PT (1) PT97504A (pt)
WO (1) WO1991016058A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
US6537977B1 (en) * 1995-09-19 2003-03-25 Seikagaku Corporation Anti-inflammatory agent
JP2001187740A (ja) * 2000-01-05 2001-07-10 Seikagaku Kogyo Co Ltd 創傷治療剤
FR2833268B1 (fr) * 2001-12-12 2005-07-08 Fabre Pierre Dermo Cosmetique Nouvelle association contenant un poloxamer et de l'acide chondroitine sulfurique et/ou une glycoproteine et son utilisation
EP3677587A4 (en) 2016-08-31 2021-04-14 Oji Holdings Corporation XYLOOLIGOSACCHARIDE ACID, AND METHOD FOR MANUFACTURING THE SAME
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
JP6281659B1 (ja) 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
CA3065747C (en) 2017-05-31 2024-10-01 Oji Holdings Corporation MOISTURIZING COMPOSITION CONTAINING PENTOSANNE POLYSULFATE
PL3683242T3 (pl) 2017-09-12 2025-03-03 Oji Holdings Corporation Polisiarczan pentozanu i sposób wytwarzania polisiarczanu pentozanu
KR102533822B1 (ko) 2017-12-20 2023-05-17 오지 홀딩스 가부시키가이샤 폴리황산펜토산 및 폴리황산펜토산을 포함하는 의약
CN111228466B (zh) * 2020-02-27 2023-06-27 温州医科大学 治疗糖尿病足的含氧气微泡的水凝胶及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997458A (en) * 1974-04-12 1976-12-14 Deknatel, Incorporated Method of cleansing contaminated wounds and surgical scrub solutions for same
US4052513A (en) * 1974-12-13 1977-10-04 Plough, Inc. Stable topical anesthetic compositions
IT1212892B (it) * 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
US4745098A (en) * 1984-02-24 1988-05-17 The Regents Of The University Of California Compositions and method for improving wound healing
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
JPS61253065A (ja) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
FR2585575B1 (fr) * 1985-08-01 1989-03-03 Pf Medicament Compositions pharmaceutiques a activite keratolytique sous forme de gel comportant de l'acide salicylique hydro-alcoolique
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
CA1294546C (en) * 1986-04-23 1992-01-21 John S. Sundsmo Wound healing composition containing collagen
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor

Also Published As

Publication number Publication date
PT97504A (pt) 1992-02-28
EP0526578A1 (en) 1993-02-10
AU647484B2 (en) 1994-03-24
IE911403A1 (en) 1991-11-06
CN1058341A (zh) 1992-02-05
WO1991016058A1 (en) 1991-10-31
AU7869291A (en) 1991-11-11
EP0526578A4 (en) 1993-09-22
JPH0776175B2 (ja) 1995-08-16
JPH05506861A (ja) 1993-10-07
IL97976A0 (en) 1992-06-21
CA2081340A1 (en) 1991-10-27

Similar Documents

Publication Publication Date Title
BR8900357A (pt) Composicao e processo de tratamento de tecido e processo para a preparacao da dita composicao
BR8900948A (pt) Composicao aquosa condicionadora de tecidos e processo para tratamento de tecidos
BR9106377A (pt) Composicao e processo para o tratamento topico de tecido lesado ou enfermo
FI963696L (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
PT93791A (pt) Dispositivo para tratamento de residuos medicos especiais
BR9000990A (pt) Composicao aquosa condicionadora de tecidos e processo para o tratamento de tecidos
BR8305329A (pt) Atadura e processo para tratar dor e/ou inflamacao
BR9612204A (pt) Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor
BR8300475A (pt) Composto, composicao farmaceutica, processo para tratamento de infeccao virotica em um animal de sangue quente ou de sangue frio, e processo para a preparacao de tal composto
BR9408148A (pt) Processo para tratamento de arritmia composto e formulação farmacêutica
PT88972A (pt) Processo para a preparacao de uma composicao util para o tratamento do cabelo ou da pele
DE68916036D1 (de) Mittel zur behandlung und prophylaxe koronarer und zerebraler ischämischer erkrankungen.
KR920700634A (ko) 좌창 또는 건선 피부병을 치료하는 방법 및 여기에 사용되는 조성물
BR8900962A (pt) Composicao bactericida e processo de tratamento
BR9506581A (pt) Composto composição farmacêutica uso do composto processo para a profilaxia ou tratamento de uma condição clínica em um manífero por exemplo um humano e para a preparação de um composto e composto intermediário
BR9708607A (pt) Composto composição farmacéutica utilização de um composto processo para tratamento ou redução do risco de doença inflamatória num paciente e para a preparação de um composto e intermediário químico
BR8801105A (pt) Composicoes para cuidados da pele e metodo para o tratamento da pele
BR9105287A (pt) Composicao e processo para o tratamento do cabelo
BR9502471A (pt) Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica
PT82608A (pt) Processo para o tratamento de sementes e sementes assim tratadas
BR8901135A (pt) Composicao para condicionamento de tecido e processo para tratar tecidos
BR9510015A (pt) Composto composição farmacéutica e processo para o tratamento de doenças enfecciosas em terapia humana ou veterinária
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
BR9708864A (pt) Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero
DE69214299D1 (de) Verwendung von alkylpolyglycosiden und/oder 0-acylierte glukosederivate zur behandlung des haarausfalls

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal